Literature DB >> 12554800

Activity and subcellular distribution of cathepsins in primary human monocytes.

Andrea Greiner1, Alfred Lautwein, Herman S Overkleeft, Ekkehard Weber, Christoph Driessen.   

Abstract

Cathepsins (Cat) in antigen presenting cells (APC) control antigen processing as well as major histocompatibility complex class II transport and function. The set of active Cat and the subcellular architecture of the class II antigen presentation compartment are largely unknown in primary human APC, including peripheral blood monocytes. We used novel chemical tools to visualize Cat in an activity-dependent manner. Primary human monocytes contained active CatS, -B, and -H, while CatL was absent. Expression and activity patterns of Cat in human myelo-monocytoid cell lines were distinct from those found in primary cells. On a subcellular scale, the bulk of active Cat was concentrated in lysosomes in primary monocytes. In late endosomes, only active CatS was found in sizable amounts, colocalizing with C-terminal processing of the class II invariant chain and with cystatin C, the major endogenous Cat inhibitor. Late endosomes of human peripheral blood monocytes contain a well-controlled proteolytic machinery distinct from lysosomes, which is likely to play a key role in class II function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554800     DOI: 10.1189/jlb.0802398

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imaging.

Authors:  Wen Shi; Sunny M Ogbomo; Nilesh K Wagh; Zhengyuan Zhou; Yinnong Jia; Susan K Brusnahan; Jered C Garrison
Journal:  Biomaterials       Date:  2014-04-19       Impact factor: 12.479

2.  Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro.

Authors:  Timo Burster; Alexander Beck; Simone Poeschel; Anita Øren; Daniel Baechle; Michael Reich; Olaf Roetzschke; Kirsten Falk; Bernhard O Boehm; Sawsan Youssef; Hubert Kalbacher; Herman Overkleeft; Eva Tolosa; Christoph Driessen
Journal:  Immunology       Date:  2007-02-14       Impact factor: 7.397

3.  Diminished intracellular invariant chain expression after vaccinia virus infection.

Authors:  Nan Wang; Ekkehard Weber; Janice S Blum
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

4.  CSF proteomic fingerprints for HIV-associated cognitive impairment.

Authors:  Juliana Pérez Laspiur; Eric R Anderson; Pawel Ciborowski; Valerie Wojna; Wojciech Rozek; Fenghai Duan; Raul Mayo; Elaine Rodríguez; Marinés Plaud-Valentín; José Rodríguez-Orengo; Howard E Gendelman; Loyda M Meléndez
Journal:  J Neuroimmunol       Date:  2007-10-22       Impact factor: 3.478

5.  HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase.

Authors:  Andrew N Harman; Marianne Kraus; Chris R Bye; Karen Byth; Stuart G Turville; Owen Tang; Sarah K Mercier; Najla Nasr; Josh L Stern; Barry Slobedman; Christoph Driessen; Anthony L Cunningham
Journal:  Blood       Date:  2009-05-12       Impact factor: 22.113

6.  CD4-independent human immunodeficiency virus infection involves participation of endocytosis and cathepsin B.

Authors:  Hiroaki Yoshii; Haruka Kamiyama; Kensuke Goto; Kazunori Oishi; Nobuhiko Katunuma; Yuetsu Tanaka; Hideki Hayashi; Toshifumi Matsuyama; Hironori Sato; Naoki Yamamoto; Yoshinao Kubo
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

7.  Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance.

Authors:  M Kraus; J Bader; H Overkleeft; C Driessen
Journal:  Blood Cancer J       Date:  2013-03-01       Impact factor: 11.037

8.  Subcellular fractionation method to study endosomal trafficking of Kaposi's sarcoma-associated herpesvirus.

Authors:  Lia R Walker; Hosni A M Hussein; Shaw M Akula
Journal:  Cell Biosci       Date:  2016-01-15       Impact factor: 7.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.